Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • من نحن
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
    • تاريخ الجمعية
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin May 22, 2025 0

2025 Summary: ANOCA, INOCA, and MINOCA – Clinical Overview

2025 Summary: ANOCA, INOCA, and MINOCA – Clinical Overview
1-ANOCA (Angina with No Obstructive Coronary Arteries): Clinical term for chest pain without major coronary obstruction (<50%). May be ischemic or non-ischemic.
2-INOCA (Ischemia with No Obstructive Coronary Arteries): Confirmed myocardial ischemia (via stress testing or imaging), but no significant CAD on angiography. Common in women.
3- MINOCA(MI with Non-Obstructive Coronary Arteries): Fulfills MI criteria (troponin elevation, ECG changes) but coronary arteries show no >50% stenosis.
4- Evaluation Strategy:
  – Rule out alternate diagnoses (e.g. PE, sepsis, myocarditis)
  – Use OCT/IVUS for plaque disruption or SCAD
  – Cardiac MRI to distinguish takotsubo/myocarditis
  – Use CFR, IMR, and provocative tests if available.
5- Treatment:
  – Tailored by mechanism
  – Atherosclerotic: statins, ACEi, BB, antiplatelets
  – Vasospasm: CCBs, nitrates
  – Microvascular: BB, ACEi, statins
  – Avoid unnecessary dual antiplatelet therapy.
6- Prognosis:
  – Previously thought benign, now known to have 4–5% 1-year mortality
  – Increased risk of recurrent angina, heart failure, especially in women.
7- Clinical Tip:
  – INOCA and ANOCA are often underdiagnosed
  – Mislabeling as ‘non-cardiac chest pain’ leads to under-treatment
8- Patient scenario:
A 52-year-old woman comes to your clinic complaining of chest pain. Her ECG is non-diagnostic, and cardiac enzymes are slightly elevated. Coronary angiography shows no significant blockage (<50%).
  9- Quick Summary – INOCA, Microvascular Angina, and Variant Angina (Prinzmetal’s):
• INOCA stands for Ischemia with No Obstructive Coronary Arteries. It refers to chest pain or signs of myocardial ischemia without significant coronary artery blockages.
• Microvascular angina is a subtype of INOCA caused by dysfunction of the small coronary vessels (microcirculation). It’s often exercise-induced and not visible on traditional angiograms.
• Variant angina (also called Prinzmetal’s angina) is also a form of INOCA, but caused by spasm in the large epicardial coronary arteries, usually at rest and often with transient ST-elevation.
Key difference:
• Microvascular angina = small vessel dysfunction
• Variant angina = large vessel (epicardial) spasm
Now what?
Step-by-step Evaluation:
1. First, rule out other serious conditions:
• Could it be pulmonary embolism, sepsis, or myocarditis?
→ Do basic labs, imaging, and consider Cardiac MRI to check for myocarditis or Takotsubo cardiomyopathy.
2. If MI is suspected but arteries are clear:
• Think about plaque rupture or SCAD (spontaneous dissection).
→ Use OCT or IVUS during angiography to detect subtle findings missed by standard imaging.
3. If chest pain persists and ischemia is suspected:
• Assess for microvascular angina or vasospasm.
→ Perform CFR (coronary flow reserve), IMR, or acetylcholine testing if available.
Reference (2025):
  – 2025 ESC Insights on INOCA/MINOCA: https://www.escardio.org/Congresses-&-Events/Congress-Resources/2025/inoca-minoca-clinical-management
  – AHA Scientific Statement: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000963
128 Views
14
Risk Scores & Tools for Predicting Cardiovascular Risk in Asymptomatic IndividualsMay 22, 2025
Recent studies and guidelines suggest that female sex alone may not independently increase stroke risk in atrial fibrillation (AF) patients. May 22, 2025

مقالات ذات صلة

Uncategorized

Nurses Developing Mysterious Brain Tumors

webadmin April 13, 2025
Uncategorized

Impact of Preference Signaling on Radiology Residency Placements (Source: Academic Radiology – August 5, 2025)

jordan heart August 10, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • Early HF Screening Algorithm in Primary Care
  • Beta-Blockers after MI without Reduced Ejection Fraction
  • POTCAST Trial 
  • DIGIT-HF Trial 
  • Late-Breaking Trials & Science – TCT 2025 (San Francisco, Oct 25–28)

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.